Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02227654 · ClinicalTrials.gov registry record · NA
Evaluating the Performance of Morphology Index in Surgical Decision-Making for Ovarian Tumors
A NA study, sponsored by Frederick R. Ueland, M.D..
- Completed
- Registry status
- NA
- Development phase
- 179
- Enrollment target
NCT02227654: Completed NA study, sponsored by Frederick R. Ueland, M.D..
NCT02227654 is a NA study that has completed, run by Frederick R. Ueland, M.D.. The registered enrollment target is 179 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (87% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02227654, a NA study, has completed, sponsored by Frederick R. Ueland, M.D..
- COMPLETED
- Registry status
- NA
- Development phase
- 179 participants
- Enrollment target
Study Summary
The present investigation will prospectively evaluate whether serial transvaginal ultrasonography with Morphology Index (MI) can further reduce false positive results by more accurately distinguishing benign from malignant ovarian tumors. If there is no change in the detection of true positive cases, the result will be an increase in the positive predictive value of ovarian cancer screening.
Primary Outcome
Whether the treatment algorithm for patients with abnormal ultrasounds improves the positive predictive value of ultrasounds as ovarian screening tests, thus lowering the false positive rate compared to historical controls.
Interventions
- PROCEDURE Abnormal Ovarian Ultrasound
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 179 participants |
| Start Date | 2016-09-12 |
| Est. Completion | 2022-09-07 |
| Phase | NA |
What the finished NCT02227654 record still lists
NCT02227654 is an interventional study that assigns participants to a tested intervention. The registered 179 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (87% lower).
The record links to 0 conditions, and to 1 intervention - of which Abnormal Ovarian Ultrasound is the first listed.
NCT02227654 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02227654 about?
NCT02227654 is a clinical study titled "Evaluating the Performance of Morphology Index in Surgical Decision-Making for Ovarian Tumors". The present investigation will prospectively evaluate whether serial transvaginal ultrasonography with Morphology Index (MI) can further reduce false positive results by more accurately distinguishing benign from malignant ovarian tumors. If there is no change in the detection of true positive cases...
What is the current status of trial NCT02227654?
This trial is currently completed. It is a NA study. The enrollment target is 179 participants. The study started on 2016-09-12. Estimated completion is 2022-09-07.
What interventions are being tested in trial NCT02227654?
The interventions under investigation include: Abnormal Ovarian Ultrasound (PROCEDURE).
Who is sponsoring clinical trial NCT02227654?
This trial is sponsored by Frederick R. Ueland, M.D., which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02227654's enrollment target sits among peer trials
179 604th of 2000 higher than 1,397 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06581198 · 179 participants · Phase 2
A Study of Rapcabtagene Autoleucel in Active, Refractory Systemic Lupus Erythematosus (SLE) or Lupus Nephritis (LN) Patients (AUTOGRAPH - SLE/LN)
- NCT07356323 · 179 participants · NA
A Prospective, Single-arm, Trial to Determine Contamination Rates When Using an Antibacterial Incise Drape During Orthopedic Surgery
- NCT01558804 · 180 participants
GRoup A StrePtococcus
- NCT02932176 · 180 participants
Machine Learning for Handheld Vascular Studies
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI